--- title: Colon26 Syngeneic Model - TD2 Precision Oncology description: Explore Colon26, a murine colon carcinoma cell line used in colorectal cancer research. Study tumor biology, therapeutic interventions, and treatment efficacy. image: https://td2inc.com/hubfs/Assets/GraphsFigures/colon26.png --- ×   [![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en) ![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png) [![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en) ![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png) # Colon26 Syngeneic Model **Synonyms:** Colon-26 murine colon carcinoma cell line, Colon-26 Colon26 is a widely studied cancer cell line derived from a murine colon carcinoma. It is commonly used as a preclinical model to investigate various aspects of colorectal cancer, including tumor growth, metastasis, and therapeutic interventions. Colon26 cells exhibit characteristics similar to human colorectal cancer, making them valuable for studying the disease. They have an epithelial morphology and can form tumors when implanted in animal models. Researchers utilize Colon26 to explore genetic alterations, signaling pathways, immune responses, and drug sensitivity in colorectal cancer. It has been extensively employed in preclinical models to evaluate the efficacy of different treatment approaches, such as chemotherapy, immunotherapy, targeted therapies, and combination treatments. The Colon26 cell line plays a crucial role in advancing our understanding of colorectal cancer and developing novel strategies for its diagnosis and treatment. ## Model Details **Cancer Type:** Colorectal Cancer **Model Name:** Colon26 **Mouse Strain:** balb/c **Treatment Data Available:** Chemotherapy ## Colon26 Growth Curves: Response to 5-FU ![Colon26 Syngeneic Model](https://td2inc.com/hubfs/Assets/GraphsFigures/colon26.png) Growth of subcutaneous Colon26 in balb/c mice (n=10). Response to 5-FU dosed QDx5. ### Request Additional Syngeneic Model Data ## CONTACT US ## Get Started. Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started. [Get Started Now](https://td2inc.com/contact-us/?hsLang=en) [![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/td2-logo.png?width=160&name=td2-logo.png)](https://td2inc.com/?hsLang=en) Office 13208 E. Shea Blvd, Suite 100 Scottsdale, AZ 85259 Phone (602) 358-8300 Connect with us - - ![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/Assets/Logo/acclac-logo.png?width=139&name=acclac-logo.png) © 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)